CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Medipost Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Medipost Co Ltd
21
Daewangpangyo-ro 644beon-gil
Phone: +82 234656677p:+82 234656677 SEONGNAM, 13494  South Korea Ticker: 078160078160
Business Summary
MEDIPOST Co., Ltd. is a Korea-based company engaged in the biotechnology business. The Company mainly operates cord blood banks. Its cord blood banks consist of public cord blood bank, which provides resource to anyone who may need to undergo hematopoietic stem cell transplantation (HSCT) as a result of blood-related diseases, such as leukemia or aplastic anemia, as well as family cord blood bank, which provides services for storing newborn’s cord blood exclusively for family’s use. It also involves in the provision of stem cell drugs, which are used for recovery of knee articular cartilage and others, distribution of healthcare food and natural cosmetics, as well as provision of healthcare services.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
8099 Health and allied services, not elsewhere classified
2836 Biological products, except diagnostic substances
5149 Groceries and related products, not elsewhere classified
5122 Drugs, drug proprietaries, and druggists' sundries
6512 Operators of nonresidential buildings

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Dong JinHwang 60 3/29/2022 9/1/2006
Chief Executive Officer, Director Won YilOh 60 8/8/2022
Vice President, Director Jang WonLee 56 1/1/2012 3/25/2011
12 additional Officers and Directors records available in full report.

Business Names
Business Name
078160
Medi Post Co., Ltd.

General Information
Number of Employees: 209 (As of 3/31/2016)
Outstanding Shares: 34,098,785 (As of 12/31/2023)
Shareholders: 23,228
Stock Exchange: KDQ
Fax Number: +82 234656688


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024